MA56098A - Immunomodulateurs hétérocycliques utilisés comme inhibiteur de point de contrôle pdl1 - Google Patents
Immunomodulateurs hétérocycliques utilisés comme inhibiteur de point de contrôle pdl1Info
- Publication number
- MA56098A MA56098A MA056098A MA56098A MA56098A MA 56098 A MA56098 A MA 56098A MA 056098 A MA056098 A MA 056098A MA 56098 A MA56098 A MA 56098A MA 56098 A MA56098 A MA 56098A
- Authority
- MA
- Morocco
- Prior art keywords
- heterocyclic
- checkpoint inhibitor
- immunomodulators used
- pdl1
- pdl1 checkpoint
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19179072 | 2019-06-07 | ||
| PCT/EP2020/065646 WO2020245372A1 (fr) | 2019-06-07 | 2020-06-05 | Immunomodulateurs hétérocycliques utilisés comme inhibiteur de point de contrôle pdl1 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA56098A true MA56098A (fr) | 2022-04-13 |
| MA56098B1 MA56098B1 (fr) | 2023-10-31 |
Family
ID=66793871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA56098A MA56098B1 (fr) | 2019-06-07 | 2020-06-05 | Immunomodulateurs hétérocycliques autant qu'inhibiteurs de pdl1 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20220259186A1 (fr) |
| EP (1) | EP3980413B1 (fr) |
| JP (1) | JP7768770B2 (fr) |
| KR (1) | KR102939670B1 (fr) |
| CN (1) | CN113966329B (fr) |
| AU (1) | AU2020286962B2 (fr) |
| BR (1) | BR112021023780A2 (fr) |
| CA (1) | CA3138494A1 (fr) |
| ES (1) | ES2956866T3 (fr) |
| HR (1) | HRP20230873T1 (fr) |
| HU (1) | HUE063236T2 (fr) |
| MA (1) | MA56098B1 (fr) |
| MD (1) | MD3980413T2 (fr) |
| MX (1) | MX2021015048A (fr) |
| PL (1) | PL3980413T3 (fr) |
| RS (1) | RS64681B1 (fr) |
| SM (1) | SMT202300280T1 (fr) |
| WO (1) | WO2020245372A1 (fr) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4815773B2 (ja) * | 2003-09-17 | 2011-11-16 | 住友化学株式会社 | シンナモイル化合物及びその用途 |
| CN105705489B (zh) * | 2013-09-04 | 2019-04-26 | 百时美施贵宝公司 | 用作免疫调节剂的化合物 |
| US9850225B2 (en) * | 2014-04-14 | 2017-12-26 | Bristol-Myers Squibb Company | Compounds useful as immunomodulators |
| US10639284B2 (en) * | 2016-06-27 | 2020-05-05 | Chemocentryx, Inc. | Immunomodulator compounds |
| EA201990221A1 (ru) * | 2016-07-08 | 2019-06-28 | Бристол-Маерс Сквибб Компани | 1,3-дигидроксифенильные производные, применимые в качестве иммуномодуляторов |
| CN110461829B (zh) * | 2017-03-27 | 2023-02-28 | 百时美施贵宝公司 | 作为免疫调节剂的取代的异喹啉衍生物 |
-
2020
- 2020-06-05 JP JP2021572339A patent/JP7768770B2/ja active Active
- 2020-06-05 EP EP20730279.5A patent/EP3980413B1/fr active Active
- 2020-06-05 WO PCT/EP2020/065646 patent/WO2020245372A1/fr not_active Ceased
- 2020-06-05 HR HRP20230873TT patent/HRP20230873T1/hr unknown
- 2020-06-05 CA CA3138494A patent/CA3138494A1/fr active Pending
- 2020-06-05 US US17/595,711 patent/US20220259186A1/en active Pending
- 2020-06-05 RS RS20230805A patent/RS64681B1/sr unknown
- 2020-06-05 HU HUE20730279A patent/HUE063236T2/hu unknown
- 2020-06-05 MD MDE20220403T patent/MD3980413T2/ro not_active IP Right Cessation
- 2020-06-05 PL PL20730279.5T patent/PL3980413T3/pl unknown
- 2020-06-05 KR KR1020217042602A patent/KR102939670B1/ko active Active
- 2020-06-05 CN CN202080041699.XA patent/CN113966329B/zh active Active
- 2020-06-05 SM SM20230280T patent/SMT202300280T1/it unknown
- 2020-06-05 MX MX2021015048A patent/MX2021015048A/es unknown
- 2020-06-05 BR BR112021023780A patent/BR112021023780A2/pt unknown
- 2020-06-05 AU AU2020286962A patent/AU2020286962B2/en active Active
- 2020-06-05 MA MA56098A patent/MA56098B1/fr unknown
- 2020-06-05 ES ES20730279T patent/ES2956866T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MX2021015048A (es) | 2022-01-18 |
| EP3980413B1 (fr) | 2023-07-19 |
| JP2022535879A (ja) | 2022-08-10 |
| WO2020245372A1 (fr) | 2020-12-10 |
| ES2956866T3 (es) | 2023-12-29 |
| MA56098B1 (fr) | 2023-10-31 |
| KR20220017942A (ko) | 2022-02-14 |
| US20220259186A1 (en) | 2022-08-18 |
| CN113966329B (zh) | 2024-08-13 |
| JP7768770B2 (ja) | 2025-11-12 |
| HUE063236T2 (hu) | 2024-01-28 |
| AU2020286962A1 (en) | 2022-02-03 |
| KR102939670B1 (ko) | 2026-03-13 |
| EP3980413A1 (fr) | 2022-04-13 |
| HRP20230873T1 (hr) | 2024-02-16 |
| MD3980413T2 (ro) | 2023-12-31 |
| CN113966329A (zh) | 2022-01-21 |
| RS64681B1 (sr) | 2023-11-30 |
| BR112021023780A2 (pt) | 2022-01-11 |
| PL3980413T3 (pl) | 2023-12-27 |
| EP3980413C0 (fr) | 2023-07-19 |
| AU2020286962B2 (en) | 2025-10-16 |
| CA3138494A1 (fr) | 2020-12-10 |
| SMT202300280T1 (it) | 2023-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4069212A4 (fr) | Inhibiteurs de hif-2 alpha | |
| EP4007752C0 (fr) | Inhibiteurs de kif18a | |
| DK3873903T3 (da) | Substituerede 6-azabenzimidazolforbindelser som hpk1-hæmmere | |
| DK4219492T3 (da) | Heterocykliske forbindelser som immunmodulatorer | |
| DK4212529T3 (da) | Heterocykliske forbindelser som immunmodulatorer | |
| EP3843714C0 (fr) | Inhibiteurs de cd73 | |
| EP4007756C0 (fr) | Inhibiteurs de kif18a | |
| DK3684767T3 (da) | Heterocykliske forbindelser som pad-inhibitorer | |
| JP1679815S (ja) | エアロゾル発生器用充電器 | |
| DE102020112518B8 (de) | Toner | |
| MA55633A (fr) | Salicylamides de spiroheptane et composés associés utilisés comme inhibiteurs de rock | |
| DK3704120T3 (da) | Heterocykliske forbindelser som prmt5-inhibitorer | |
| MA46045A (fr) | Composés hétérocycliques utilisés comme immunomodulateurs | |
| IL289439A (en) | Heterocyclic compounds as bet inhibitors | |
| MA44860A (fr) | Composés hétérocycliques utilisés comme immunomodulateurs | |
| DK3697785T3 (da) | Imidazo-pyridine forbindelser som pad-inhibitorer | |
| IL284591A (en) | Fxr (nr1h4) modulating compounds | |
| DK3442980T3 (da) | Heterocykliske forbindelser som ret-kinase-hæmmere | |
| DK3768674T3 (da) | Aminopyrimidinderivater som ctps1-hæmmere | |
| EP3966213A4 (fr) | Inhibiteurs de cdk | |
| MA46203A (fr) | Utilisations d'un inhibiteur d'homologue 2 de lysyl-oxydase | |
| EP3946936A4 (fr) | Couvercle recyclable haute performance | |
| EP3801500A4 (fr) | Inhibiteurs de sarm1 | |
| EP3980011A4 (fr) | Inhibiteurs de sarm1 | |
| DK4055021T3 (da) | Heterocykliske rip1-inhiberende forbindelser |